Related Experiment Video
Updated: Oct 6, 2025

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Adalimumab-Induced Erythema Multiforme in a Patient With Rheumatoid Arthritis: A Case Report
Jinan Q Mohammed1, Zainab Mahmmod2, Abdulsatar J Mathkhor3
1Dermatology, Basrah Teaching Hospital, Basrah, IRQ.
Abstract:
Tumor necrosis factor-alpha (TNF-α) inhibitors are a group of biological medications that revolutionized the treatment of rheumatoid arthritis (RA) and several other inflammatory autoimmune diseases. The wide use of these drugs has been associated with some adverse reactions. Erythema multiforme (EM) is an immune-mediated cutaneous disorder that represents a hypersensitivity reaction to infections, vaccines, and some medications. We present a female patient with EM with characteristic skin lesions following anti-TNF-α medication adalimumab for rheumatoid arthritis.
More Related Videos
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management